Cellyan Biotechnology (HKPD)

• Market cap: $14.6M
• 1 day: -2.75%
• 5 days: -9.14%
• 1 month: 21.49%
• 3 months: -24.44%
• 6 months: -48.13%
• Year to date: -22.86%
• 1 year: -30.08%
• 5 years: -77.93%
• 10 years: -77.93%
• Sector: Healthcare
• Industry: Medical Distribution

About: Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

Employees: 27